Literature DB >> 18528840

Towards standard protocols and guidelines for urine proteomics: a report on the Human Kidney and Urine Proteome Project (HKUPP) symposium and workshop, 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA.

Tadashi Yamamoto1, Robyn G Langham, Pierre Ronco, Mark A Knepper, Visith Thongboonkerd.   

Abstract

The Human Kidney and Urine Proteome Project (HKUPP) was initiated in 2005 to promote proteomics research in the nephrology field, to better understand kidney functions as well as pathogenic mechanisms of kidney diseases, and to define novel biomarkers and therapeutic targets. This project was first approved in 2005 by the Human Proteome Organisation (HUPO) as a Kidney Disease Initiative under an umbrella of the HUPO Disease Biomarker Initiative (DBI), and more recently was approved as the HKUPP Initiative in 2007. Several sub-projects have been planned to achieve the ultimate goals. The most pressing is the establishment of "standard protocols and guidelines for urine proteome analysis". This sub-project had been extensively discussed during the first HKUPP symposium (during 6(th) HUPO Annual World Congress--October 2007, Seoul, Korea) and second workshop (during 40(th) American Society of Nephrology Renal Week--November 2007, San Francisco, CA, USA). Additional data and references have been collected after the symposium and workshop. An initial draft of standard protocols and guidelines for proteome analysis of non-proteinuric urine (urine protein excretion < or =150 mg/day) will soon be released as the first HKUPP product.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528840     DOI: 10.1002/pmic.200800138

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  19 in total

Review 1.  Proteomics and systems biology: current and future applications in the nutritional sciences.

Authors:  J Bernadette Moore; Mark E Weeks
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

Review 2.  The application of mass-spectrometry-based protein biomarker discovery to theragnostics.

Authors:  Jonathan M Street; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

3.  Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics.

Authors:  L Katie Crosley; Susan J Duthie; Abigael C Polley; Freek G Bouwman; Carolin Heim; Francis Mulholland; Graham Horgan; Ian T Johnson; Edwin C Mariman; Ruan M Elliott; Hannelore Daniel; Baukje de Roos
Journal:  Genes Nutr       Date:  2009-04-29       Impact factor: 5.523

Review 4.  Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

Authors:  Massimo Papale; Salvatore Di Paolo; Grazia Vocino; Maria Teresa Rocchetti; Loreto Gesualdo
Journal:  J Nephrol       Date:  2014-02-25       Impact factor: 3.902

Review 5.  Current state of the art for enhancing urine biomarker discovery.

Authors:  Michael Harpole; Justin Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2016-06       Impact factor: 3.940

6.  Challenges and opportunities for discovery of disease biomarkers using urine proteomics.

Authors:  Alex Kentsis
Journal:  Pediatr Int       Date:  2011-02       Impact factor: 1.524

Review 7.  Proteomics and opportunities for clinical translation in urological disease.

Authors:  Ali R Vaezzadeh; Hanno Steen; Michael R Freeman; Richard S Lee
Journal:  J Urol       Date:  2009-07-17       Impact factor: 7.450

Review 8.  Big Data in Nephrology.

Authors:  Navchetan Kaur; Sanchita Bhattacharya; Atul J Butte
Journal:  Nat Rev Nephrol       Date:  2021-06-30       Impact factor: 28.314

Review 9.  Urinary proteomic profiling for diagnostic bladder cancer biomarkers.

Authors:  Steve Goodison; Charles J Rosser; Virginia Urquidi
Journal:  Expert Rev Proteomics       Date:  2009-10       Impact factor: 3.940

10.  Common sense approaches to urinary biomarker study design.

Authors:  Mark A Knepper
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.